Skip to main content

Table 1 Patient demography and clinical status of the study participants

From: High viremia and low level of transmitted drug resistance in anti-retroviral therapy-naïve perinatally-infected children and adolescents with HIV-1 subtype C infection

 

Over all (n = 105)

<5 years (n = 17)

≥5 to <10 years (n = 49)

≥10 years (n = 39)

Sex: Male (%)

61 (58.1%)

12 (70%)

29 (59%)

20(51%)

CD4-T cell count

530 (338–780)

1051 (528–1154)

586 (401–768)

373 (251–578)

Median (IQR*)

Viral load log copies/mL

5.24 (4.62-5.66)

5.56 (5.51-6.05)

5.12 (4.55-5.55)

5.2 (4.73-5.63)

Median (IQR*)

WHO Clinical stage

Stage 1

40 (38.1%)

6 (35.3%)

19 (38.7%)

15 (38.5%)

Stage 2

37 (35.2%)

5 (29.4%)

19 (38.7%)

13 (33.3%)

Stage 3

22 (21%)

4 (23.5%)

9 (18.4%)

9 (23.1%)

Stage 4

6 (5.7%)

2 (11.8%)

02 (4.1%)

2 (5.1%)

  1. *IQR: Inter-quartile range.